Radiotherapy is used in> 50% of patients with cancer, both for curative and palliative
purposes. Radiotherapy uses ionizing radiation to target and kill tumour tissue, but normal …

Over the past decades, technological advances have transformed radiation therapy (RT) into
a precise and powerful treatment for cancer patients. Nevertheless, the treatment of radiation …

Background When compared to conventional radiotherapy (RT) in pre-clinical studies,
FLASH-RT was shown to reproducibly spare normal tissues, while preserving the anti-tumor …

Radiation pneumonitis (RP) and radiation fibrosis (RF) are two dose-limiting toxicities of
radiotherapy (RT), especially for lung, and esophageal cancer. It occurs in 5–20% of …

In vitro studies suggested that sub-millisecond pulses of radiation elicit less genomic
instability than continuous, protracted irradiation at the same total dose. To determine the …

To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …

Background With increasingly precise radiotherapy and advanced medical imaging, the
concept of radiotherapy target volume planning might be redefined with the aim of improving …

A high proportion of NSCLC patients present with symptoms in advanced disease stage.
The aim of lung cancer screening is to reduce lung cancer-related mortality by detecting …

Lung, breast, and esophageal cancer represent three common malignancies with high
incidence and mortality worldwide. The management of these tumors critically relies on …

Objectives Chemo-radiotherapy (CRT) and concurrent PD-1 inhibition has shown promising
results in pre-clinical models. So far, the feasibility of delivering concurrent CRT and PD …